Document Detail


Healthy outcome under olanzapine treatment in a pregnant woman.
MedLine Citation:
PMID:  10761825     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Our report focuses on the case of a pregnant women with recurrent, paranoid schizophrenia. The patient was treated with Olanzapine from the 18th gestational week until delivery and during breast-feeding. No adverse events occurred during pregnancy, and the outcome was healthy. After delivery, the plasma level of olanzapine in the infant was one-third of the maternal plasma level, and during breast-feeding, it decreased to an undetectable limit.
Authors:
J Kirchheiner; A Berghöfer; D Bolk-Weischedel
Related Documents :
2311815 - Influence of parity on plasma lipid levels.
19467325 - 17beta-estradiol treatment is unable to reproduce p85 alpha redistribution associated w...
1325515 - Acute and chronic regulation of atrial natriuretic peptide in human pregnancy: a longit...
7429885 - Biological and clinical significance of pregnancy-associated alpha2-glycorprotein (alph...
7236005 - On the influence of zinc on mercury/selenium interaction.
3576895 - Duration of involuntary infertility and subsequent pregnancy.
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Pharmacopsychiatry     Volume:  33     ISSN:  0176-3679     ISO Abbreviation:  Pharmacopsychiatry     Publication Date:  2000 Mar 
Date Detail:
Created Date:  2000-06-09     Completed Date:  2000-06-09     Revised Date:  2008-11-21    
Medline Journal Info:
Nlm Unique ID:  8402938     Medline TA:  Pharmacopsychiatry     Country:  GERMANY    
Other Details:
Languages:  eng     Pagination:  78-80     Citation Subset:  IM    
Affiliation:
Institute for Clinical Pharmacology, Charité, Humboldt University Berlin, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Antipsychotic Agents / adverse effects*,  therapeutic use*
Benzodiazepines
Breast Feeding
Female
Humans
Infant, Newborn
Maternal-Fetal Exchange
Pirenzepine / adverse effects,  analogs & derivatives*,  blood,  therapeutic use
Pregnancy
Pregnancy Outcome*
Schizophrenia, Paranoid / drug therapy
Chemical
Reg. No./Substance:
0/Antipsychotic Agents; 12794-10-4/Benzodiazepines; 132539-06-1/olanzapine; 28797-61-7/Pirenzepine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Are low basal serum levels of the thyroid stimulating hormone (b-TSH) a risk factor for switches int...
Next Document:  The neurological complications of achondroplasia.